|
MUL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.59759991294573E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.21410001444156E-10 |
| Normal-vs-Stage2 |
3.08199999965453E-07 |
| Normal-vs-Stage3 |
4.90999999991359E-07 |
| Normal-vs-Stage4 |
9.74680000043193E-07 |
| Stage1-vs-Stage2 |
5.429200E-01 |
| Stage1-vs-Stage3 |
7.689600E-01 |
| Stage1-vs-Stage4 |
3.859800E-01 |
| Stage2-vs-Stage3 |
7.455000E-01 |
| Stage2-vs-Stage4 |
6.749000E-01 |
| Stage3-vs-Stage4 |
4.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37240227463076E-11 |
| Normal-vs-AfricanAmerican |
1.39289999534498E-08 |
| Normal-vs-Asian |
2.175000E-04 |
| Caucasian-vs-AfricanAmerican |
7.585600E-01 |
| Caucasian-vs-Asian |
5.856600E-01 |
| AfricanAmerican-vs-Asian |
5.578400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.16671166856031E-12 |
| Normal-vs-Female |
9.62489999922767E-08 |
| Male-vs-Female |
1.790970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.25529997507812E-09 |
| Normal-vs-Extreme_Weight |
4.69370098343802E-11 |
| Normal-vs-Obese |
2.31440000497685E-09 |
| Normal-vs-Extreme_Obese |
5.023800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.716200E-01 |
| Normal_Weight-vs-Obese |
7.041400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.371410E-01 |
| Extreme_Weight-vs-Obese |
9.711400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.664800E-01 |
| Obese-vs-Extreme_Obese |
1.653760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.500400E-03 |
| Normal-vs-Age(41-60Yrs) |
9.84250458913039E-11 |
| Normal-vs-Age(61-80Yrs) |
2.35179653529372E-11 |
| Normal-vs-Age(81-100Yrs) |
3.32530000202169E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.742800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.614200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.428000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.491200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.661200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.295000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.08639780399744E-11 |
| Normal-VS-Type2 PRCC |
5.95300031491774E-10 |
| Normal-VS-KIRP CIMP |
2.45970000001261E-06 |
| Normal-VS-Unclassified PRCC |
1.76035999999158E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.283400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.493800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.170400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.607000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.159400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.432800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.80899994773176E-09 |
| Normal-vs-N1 |
2.9921998212501E-10 |
| Normal-vs-N2 |
5.98490000000007E-05 |
| N0-vs-N1 |
1.380840E-01 |
| N0-vs-N2 |
3.566400E-01 |
| N1-vs-N2 |
7.895600E-01 |
|
|
